How has been the historical performance of Aarti Drugs?
Aarti Drugs has experienced a decline in net sales and profits from March 2021 to March 2025, with net sales dropping from INR 2,716.05 crore to INR 2,387.03 crore and profit after tax decreasing from INR 280.40 crore to INR 168.10 crore. However, total assets and cash flow from operating activities have improved during the same period.
Answer:The historical performance of Aarti Drugs shows a fluctuating trend in key financial metrics over the years.Breakdown:
Aarti Drugs' net sales have seen a decline from INR 2,716.05 crore in March 2023 to INR 2,387.03 crore in March 2025. Total operating income followed a similar trend, decreasing from INR 2,716.05 crore in March 2023 to INR 2,387.03 crore in March 2025. The total expenditure, excluding depreciation, also decreased from INR 2,410.45 crore in March 2023 to INR 2,099.97 crore in March 2025. Operating profit (PBDIT) has fluctuated, peaking at INR 441.64 crore in March 2021 and dropping to INR 303.42 crore in March 2025. Profit before tax decreased from INR 369.01 crore in March 2021 to INR 211.77 crore in March 2025, while profit after tax showed a similar decline from INR 280.40 crore in March 2021 to INR 168.10 crore in March 2025. The consolidated net profit also decreased from INR 280.41 crore in March 2021 to INR 168.16 crore in March 2025. On the balance sheet, total assets increased from INR 1,576.50 crore in March 2020 to INR 2,574.68 crore in March 2025, while total liabilities rose from INR 1,576.50 crore to INR 2,574.68 crore in the same period. Cash flow from operating activities improved from INR 133 crore in March 2023 to INR 244 crore in March 2025, although the net cash outflow was recorded at INR 2 crore in March 2025.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
